Newsroom

Newsroom

Using a Multiplexed Immunofluorescence Assay to Detect Immunosuppressive Cells and their Mechanisms in the Pancreatic Tumor Microenvironment

Literature
Read More

Using MultiOmyx™ to Analyze Correlations between Immunosuppressive Cells and Tumor-Infiltrating Lymphocytes in the Pancreatic Tumor Microenvironment

Literature
Read More

QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs

Press Release
Read More

NeoGenomics Signs Definitive Agreement to Acquire Genoptix

Press Release
Read More

MultiOmyx 101: An Introduction to Multiplexing Technology

Blog
Read More

A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignancies

Literature
Read More

NeoGenomics Schedules its Third Quarter Earnings Release for October 30, 2018

Press Release
Read More

NeoGenomics Announces Participation in NCI-MATCH Clinical Trial

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients